Jeantet advises Iris Ventures, lead investor in the usd 15 million Series B of Innerskin
Paris, 4 December 2025 – Jeantet advised Iris Ventures on the USD 15 million Series B of Innerskin, active in the modern aesthetic medicine sector. Through its 19 centers in France, Innerskin offers a distinctive approach focused on preventative facial and body care, combining high-performance technologies, holistic expertise and premium client experience, by pairing in-clinic […]
| CORPORATE – M&A – PRIVATE EQUITY